These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4297948)

  • 1. Electrolyte alterations in vascular smooth muscle and hypotensive activity of a new chalcone derivative.
    Sherman GP; Packman EW; Rossi GV
    J Pharm Sci; 1968 May; 57(5):733-7. PubMed ID: 4297948
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cold storage on calcium-related responses and electrolyte content of rabbit aortic strips.
    Carrier O; Murphy JC; Tenner TE
    Eur J Pharmacol; 1973 Nov; 24(2):225-33. PubMed ID: 4765745
    [No Abstract]   [Full Text] [Related]  

  • 3. Blockade of the effects of angiotensin, oxytocin, norepinephrine, 5-hydroxytryptamine and acetylcholine by guancydine.
    Worcel M; Papadimitriou A; Meyer P
    J Pharmacol Exp Ther; 1971 Oct; 179(1):42-6. PubMed ID: 4328887
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of angiotensin II antagonists by incorporating alpha-methylalanine or O-methylthreonine residues in angiotension II analogues.
    Khosla MC; Muñoz-Ramírez H; Hall MM; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Aug; 20(8):1051-5. PubMed ID: 894674
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterogeneity of drug receptors in different segments of rabbit thoracic aorta.
    Altura BM; Altura BT
    Eur J Pharmacol; 1970 Sep; 12(1):44-52. PubMed ID: 4319555
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypotensive effect of butein via the inhibition of angiotensin converting enzyme.
    Kang DG; Kim YC; Sohn EJ; Lee YM; Lee AS; Yin MH; Lee HS
    Biol Pharm Bull; 2003 Sep; 26(9):1345-7. PubMed ID: 12951484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by angiotensin II of noradrenaline-induced contractions of a rabbit isolated thoracic aorta.
    Day MD; Moore AF
    Br J Pharmacol; 1973 Jun; 48(2):338P-339P. PubMed ID: 4354802
    [No Abstract]   [Full Text] [Related]  

  • 8. Antihypertensive agents. II. Synthesis and hypotensive activity of certain 1,4,5-trisubstituted pyrazoles.
    Arya VP; Grewal RS; Kaul CL; Ghate SP; Mehta DV; George T
    J Pharm Sci; 1969 Apr; 58(4):432-40. PubMed ID: 4389194
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium content and force of drug-induced contractions of arterial muscle during recovery in vitro.
    Altura BM; Altura BT
    Proc Soc Exp Biol Med; 1970 Dec; 135(3):739-44. PubMed ID: 4321032
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of vasopressor responses by cadmium.
    Thind GS; Stephan KF; Blakemore WS
    Am J Physiol; 1970 Sep; 219(3):577-83. PubMed ID: 4317938
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of smooth muscle receptors for angiotensin: studies with an antagonist.
    Mimran A; Hinrichs KJ; Hollenberg NK
    Am J Physiol; 1974 Jan; 226(1):185-90. PubMed ID: 4358849
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of cadmium ions on contractile response of isolated aortas to stimulatory agents.
    Toda N
    Am J Physiol; 1973 Aug; 225(2):350-5. PubMed ID: 4352898
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in papaverine inhibition of prostaglandin-induced contraction of aortic strips from normal and spontaneously hypertensive rats (SHR).
    Levy JV
    Eur J Pharmacol; 1974 Jan; 25(1):117-20. PubMed ID: 4215660
    [No Abstract]   [Full Text] [Related]  

  • 14. A possible etiology of contractility impairment of vascular smooth muscle from spontaneously hypertensive rats.
    Shibata S; Kurahashi K; Kuchii M
    J Pharmacol Exp Ther; 1973 May; 185(2):406-17. PubMed ID: 4350041
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of norepinephrine-, angiotensin II-, and vasopressin-induced contractions of smooth muscle by acyl derivatives of adenosine-3',5'-monophosphate.
    Kreye VA; Schultz G
    Eur J Pharmacol; 1972 May; 18(3):297-302. PubMed ID: 4338476
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered ion transport in vascular smooth muscle from spontaneously hypertensive rats. Influences of aldosterone, norepinephrine, and angiotensin.
    Jones AW
    Circ Res; 1973 Nov; 33(5):563-72. PubMed ID: 4356609
    [No Abstract]   [Full Text] [Related]  

  • 17. The nitric oxide/soluble cyclic guanylase/cyclic guanosine monophosphate pathway is involved in the cardiovascular effects of a novel α1- and β-adrenoceptor antagonist.
    Kubacka M; Mogilski S; Bednarski M; Raźny K; Sapa J; Waszkielewicz AM; Marona H; Filipek B
    Pharmacology; 2014; 94(5-6):287-95. PubMed ID: 25531925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of propranolol on the vascular effects of cadmium and isoproterenol in rabbit aorta.
    Thind GS
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):181-91. PubMed ID: 4148407
    [No Abstract]   [Full Text] [Related]  

  • 19. Potassium induced relaxation of vascular smooth muscle: a possible mechanism of exercise hyperaemia.
    Biamino G; Wessel HJ
    Pflugers Arch; 1973 Oct; 343(2):95-106. PubMed ID: 4797856
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist.
    Wong YN; Wong PC
    J Pharm Pharmacol; 1996 May; 48(5):492-7. PubMed ID: 8799873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.